Experts discuss the evolving strategies in managing immune-related adverse events in cancer treatment, emphasizing precision immunomedicine and patient history.
Alexa Simon Meara, MD
Alexa Simon Meara, MD, is an associate professor in the Division of Oncology at The Ohio State University Wexner Medical Center James Cancer Center.
Articles by Alexa Simon Meara, MD
Discover evolving strategies for managing immune-related adverse events in cancer immunotherapy, enhancing decision-making for oncologists and practitioners.
Innovations in cancer immunotherapy highlight the urgent need for effective management of immune-related toxicities, emphasizing precision medicine and interdisciplinary collaboration.
Alexa Simon Meara, MD, discusses the importance of including a rheumatology approach to immunotherapy treatment for cancer.
Latest Updated Articles
Resources for Community Oncologists on Specialized Immunotoxicity ManagementPublished: November 13th 2025 | Updated:
- Beyond Biomarkers: Immunophenotyping Emerging as Key to Precision IRAE Management
Published: November 14th 2025 | Updated:
Exploring the IO Interface: Bridging Knowledge Gaps in Immunotoxicity ManagementPublished: November 8th 2025 | Updated: